期刊文献+

铁调素对小鼠单核细胞RAW264.7膜铁转运蛋白1(FPN1)表达的影响 被引量:2

Effect of hepcidin on the expression of ferroportin 1 in mouse RAW264.7 cells
下载PDF
导出
摘要 目的观察铁调素对小鼠单核细胞RAW264.7膜铁转运蛋白1(FPN1)的表达,探讨铁调素对RAW264.7细胞作用的可能通路和机制。方法将不同浓度的铁调素加入含有核因子κB受体活化因子配体(RANKL)的RAW264.7细胞培养基,24h后用免疫荧光和Western-blot方法测定FPN1的表达,共聚焦显微镜(CLSM)测定细胞内铁离子的浓度。结果 RAW264.7细胞膜上存在FPN1受体的阳性表达;在本实验铁调素浓度干预范围内,FPN1的表达随着铁调素浓度的增加呈浓度依赖性降低(P<0.05),同时细胞内铁离子的含量随着铁调素浓度的增加呈浓度依赖性增加(P<0.05)。结论小鼠单核细胞RAW264.7是铁调素作用的靶细胞,铁调素可通过降解其细胞膜上的FPN1增加细胞内的铁离子。 Objective To investigate the effect of hepcidin on the expression of ferroportin 1 ( FPN1 ) in RAW264.7 cells in vitro, and to explore the possible mechanism.Methods Mouse monocytes RAW264.7 were treated with different concentrations of hepcidin in the presence of receptor activator of NF-Kb ligand ( RANKL) .After 24 hours, the expression of FPN1 was detected using Western blotting and immunofluorescence, respectively.The intracellular iron concentration was measured using a confocal laser scanning microscope.Results The results documented the existence of FPN1 at the membrane of RAW264.7 cells, and the expression of FPN1 was markedly downoregulated by hepcidin in a concentration-dependent manner ( p 〈0.05 ) .Furthermore, hepcidin increased intracellular iron in RAW264.7 cells in a concentration-dependent manner (p〈0.05).Conclusion RAW264.7 cells are target cells of hepcidin.Hepcidin can increase intracellular iron by degradation of FPN1 at the membrane of RAW264.7 cells.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第12期1383-1386,1406,共5页 Chinese Journal of Osteoporosis
基金 国家自然科学基金(81273090) 江苏省自然科学基金(BK2012608) 苏州市科技基础设施建设计划之高技术研究重点实验室资助项目(SZS2012208) 苏州市科学技术项目(SS201327) 江苏省研究生创新工程项目(CX2213-0834) 镇江市科技计划项目(SH2014031)
关键词 铁调素 RAW264.7细胞 膜铁转运蛋白1 Hepcidin RAW264.7 cells Ferroportin 1
  • 相关文献

参考文献19

  • 1Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications[ J]. J Hepatol,2011,54 : 173-181.
  • 2Parrow NL, Gardenghi S, Rivella S. Prospects for a hepcidin mimic to treat beta-thalassemia and hemochromatosis [ J ]. Expert Rev Hematol,2011,4 : 233-235.
  • 3Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteoporosis and its clinical implications [ J ]. Osteoporos Int, 2012,23 : 2403- 2408.
  • 4HUANG Xi. Treatment of osteoporosis in peri- and post- menopausal women with hepcidin [ J ]. United States Patent Application Publication, Pub. No. : US 2010/0204122 A1.
  • 5赵国阳,狄东华,何银锋,沈光思,徐又佳.铁调素对小鼠单核细胞RAW264.7向破骨细胞分化的影响[J].中华骨质疏松和骨矿盐疾病杂志,2013,6(3):225-231. 被引量:3
  • 6Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization [ J]. Science ,2004,306 : 2090-2093.
  • 7徐又佳,马勇,钱忠明,郭霞,王爱东,王栋梁,冯一中,李峰,张鹏,王冰.骨质疏松模型体内铁调素(Hepcidin)基因表达的相关研究[J].中国骨质疏松杂志,2007,13(10):686-691. 被引量:17
  • 8Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin[ Jl ~ J Clin Invest, 2004,113 : 1271- 1276.
  • 9Andriopoulos B Jr, Corradini E, Xia Y, et al. BM.Ps is a key endogenous regulator of hepcidin expression and iron metabolism [ J]. Nat Genet,2009 ,41:482-487.
  • 10Zhang P, Xu Y-j, Zhao D-Y, et al. Increased intracellular iron and mineralization of cultured hFOB 1.19 cells following hepcidin activation through ferroportin-1 [ J ]. Saudi Medical Journal, 2010,31:1303-1308.

二级参考文献50

  • 1吴波,徐冰,黄添友,王金锐.维A酸致大鼠骨质疏松模型与机理研究[J].药学学报,1996,31(4):241-245. 被引量:72
  • 2徐又佳,钱忠明,俞晨.铁调素(Hepcidin)在骨质矿化中的作用[J].中国骨质疏松杂志,2005,11(4):541-543. 被引量:16
  • 3钱忠明,王琴,徐又佳,柯亚.铁调素调节蛋白(HJV)——一个新的铁代谢调节蛋白[J].生物化学与生物物理进展,2006,33(3):226-230. 被引量:11
  • 4马勇,徐又佳,王爱东,俞晨,王冰,张鹏,张振东.大鼠骨质疏松模型中肝脏Hepcidin基因表达的初步研究[J].苏州大学学报(医学版),2006,26(3):367-369. 被引量:12
  • 5Margaret MH, Linda BH, Vanessa A, et al. Dietary Iron Is Associated with Bone Mineral Density in Healthy Postmenopausal Women. Nutr, 2003, 133:3598-3602.
  • 6Isomura H, Fujie K, Shibata K, et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology, 2004, 197:93-100.
  • 7Maurer J, Harris MM, Stanford VA, et al. Dietary iron positively influences bone mineral density in postmenopausal women on hormone replacement therapy. Journal of Nutrition, 2005, 135:863-869.
  • 8Malecki EA, Buhl KM, Beard JL, et al. Bone structural and mechanical properties are affected by hypotransferrinemia but not by iron deficiency in mice. Bone Miner Res, 2000, 15:1641.
  • 9Denis MM, Aaron P, Dianne J, et al. Bone Morphology, Strength and Density Are Compromised in Iron-Deficlent Rats and Exacerbated by Calcium Restriction. J Nutr, 2002, 132:3135-3141.
  • 10Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA, 2001, 98:8160-8162.

共引文献18

同被引文献9

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部